ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson in U.S. News & World Report Ranking

July 15, 2014

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

Gonzalez-Angulo To Serve 10 Years In Poisoning Case

October 3, 2014